Therapeutic Efficacy by Targeting Correction of Notch1-Induced Aberrants in Uveal Tumors

PLoS ONE

Volumn 7, Issue 8, 2012, Pages

  Huang, Xiaolin ^a   Wang, Li ^a   Zhang, He ^a,b   Wang, Haibo ^a,b   Zhao, Xiaoping ^a   Qian, Guanxiang ^a   Hu, Jifan ^b   Ge, Shengfang ^a   Fan, Xianqun ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NOTCH1 RECEPTOR; ONCOLYTIC VIRUS; SMALL INTERFERING RNA;

ADENOVIRUS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CANCER INHIBITION; CELL CYCLE ARREST; CONTROLLED STUDY; DRUG TARGETING; FEMALE; GENE EXPRESSION; GENETIC TRANSFECTION; GROWTH INHIBITION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; SURVIVAL TIME; TUMOR XENOGRAFT; UVEA TUMOR;

APOPTOSIS; CELL CYCLE; CELL LINE, TUMOR; CELL PROLIFERATION; GENETIC THERAPY; HUMANS; MELANOMA; RECEPTOR, NOTCH1; RNA INTERFERENCE; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; UVEAL NEOPLASMS;

ADENOVIRIDAE;

EID: 84865467140     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0044301     Document Type: Article

References (47)

1. Egan KM, Seddon JM, Glynn RJ, Gragoudas ES, Albert DM, (1988) Epidemiologic aspects of uveal melanoma. Surv Ophthalmol 32: 239-251.
2. Inskip PD, Devesa SS, Fraumeni JF Jr, (2003) Trends in the incidence of ocular melanoma in the United States, 1974-1998. Cancer Causes Control 14: 251-257.
3. Damato B, Coupland SE (2009) Genomic typing of uveal melanoma. Arch Ophthalmol 127: 113-114; author reply 114-115.
4. Kujala E, Tuomaala S, Eskelin S, Kivela T, (2009) Mortality after uveal and conjunctival melanoma: which tumour is more deadly? Acta Ophthalmol 87: 149-153.
5. Triozzi PL, Eng C, Singh AD, (2008) Targeted therapy for uveal melanoma. Cancer Treat Rev 34: 247-258.
6. Zhou Y, Song X, Jia R, Wang H, Dai L, et al. (2010) Radiation-inducible human tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) gene therapy: a novel treatment for radioresistant uveal melanoma. Pigment Cell Melanoma Res 23: 661-674.
7. Fukazawa T, Matsuoka J, Yamatsuji T, Maeda Y, Durbin ML, et al. (2010) Adenovirus-mediated cancer gene therapy and virotherapy (Review). Int J Mol Med 25: 3-10.
8. Bischoff JR, Kirn DH, Williams A, Heise C, Horn S, et al. (1996) An adenovirus mutant that replicates selectively in p53-deficient human tumor cells. Science 274: 373-376.
9. Zhang H, Wang H, Zhang J, Qian G, Niu B, et al. (2009) Enhanced therapeutic efficacy by simultaneously targeting two genetic defects in tumors. Mol Ther 17: 57-64.
10. Song X, Zhou Y, Jia R, Xu X, Wang H, et al. (2010) Inhibition of retinoblastoma in vitro and in vivo with conditionally replicating oncolytic adenovirus H101. Invest Ophthalmol Vis Sci 51: 2626-2635.
11. Yu W, Fang H, (2007) Clinical trials with oncolytic adenovirus in China. Curr Cancer Drug Targets 7: 141-148.
12. Kasuya H, Takeda S, Shimoyama S, Shikano T, Nomura N, et al. (2007) Oncolytic virus therapy--foreword. Curr Cancer Drug Targets 7: 123-125.
13. Artavanis-Tsakonas S, Rand MD, Lake RJ, (1999) Notch signaling: cell fate control and signal integration in development. Science 284: 770-776.
14. Saxena MT, Schroeter EH, Mumm JS, Kopan R, (2001) Murine notch homologs (N1-4) undergo presenilin-dependent proteolysis. J Biol Chem 276: 40268-40273.
15. Harper JA, Yuan JS, Tan JB, Visan I, Guidos CJ, (2003) Notch signaling in development and disease. Clin Genet 64: 461-472.
16. Lai EC, (2004) Notch signaling: control of cell communication and cell fate. Development 131: 965-973.
17. Laws AM, Osborne BA, (2004) p53 regulates thymic Notch1 activation. Eur J Immunol 34: 726-734.
18. Lambertini C, Pantano S, Dotto GP, (2010) Differential control of Notch1 gene transcription by Klf4 and Sp3 transcription factors in normal versus cancer-derived keratinocytes. PLoS One 5: e10369.
19. Lefort K, Mandinova A, Ostano P, Kolev V, Calpini V, et al. (2007) Notch1 is a p53 target gene involved in human keratinocyte tumor suppression through negative regulation of ROCK1/2 and MRCKalpha kinases. Genes Dev 21: 562-577.
20. Yugawa T, Handa K, Narisawa-Saito M, Ohno S, Fujita M, et al. (2007) Regulation of Notch1 gene expression by p53 in epithelial cells. Mol Cell Biol 27: 3732-3742.
21. Asnaghi L, Ebrahimi KB, Schreck KC, Bar EE, Coonfield ML, et al. (2012) Notch signaling promotes growth and invasion in uveal melanoma. Clin Cancer Res 18: 654-665.
22. Yu H, Zhao X, Huang S, Jian L, Qian G, et al. (2007) Blocking Notch1 signaling by RNA interference can induce growth inhibition in HeLa cells. Int J Gynecol Cancer 17: 511-516.
23. Bin Hafeez B, Adhami VM, Asim M, Siddiqui IA, Bhat KM, et al. (2009) Targeted knockdown of Notch1 inhibits invasion of human prostate cancer cells concomitant with inhibition of matrix metalloproteinase-9 and urokinase plasminogen activator. Clin Cancer Res 15: 452-459.
24. Sonoshita M, Aoki M, Fuwa H, Aoki K, Hosogi H, et al. (2011) Suppression of colon cancer metastasis by Aes through inhibition of Notch signaling. Cancer Cell 19: 125-137.
25. Huang X, Jia R, Zhao X, Liu B, Wang H, et al. (2012) Recombinant oncolytic adenovirus H101 combined with siBCL2: cytotoxic effect on uveal melanoma cell lines. Br J Ophthalmol.
26. Masuda S, Kumano K, Shimizu K, Imai Y, Kurokawa M, et al. (2005) Notch1 oncoprotein antagonizes TGF-beta/Smad-mediated cell growth suppression via sequestration of coactivator p300. Cancer Sci 96: 274-282.
27. Oh JY, Park MY, Kim DR, Lee JH, Shim SH, et al. (2010) Combination gene therapy of lung cancer with conditionally replicating adenovirus and adenovirus-herpes simplex virus thymidine kinase. Int J Mol Med 25: 369-376.
28. Xu RH, Yuan ZY, Guan ZZ, Li S, (2005) [Reverse effect of genetically modified adenovirus H101 on drug-resistance of A549/DDP cells to cisplatin]. Ai Zheng 24: 975-979.
29. Zerp SF, van Elsas A, Peltenburg LT, Schrier PI, (1999) p53 mutations in human cutaneous melanoma correlate with sun exposure but are not always involved in melanomagenesis. Br J Cancer 79: 921-926.
30. Bergelson JM, Modlin JF, Wieland-Alter W, Cunningham JA, Crowell RL, et al. (1997) Clinical coxsackievirus B isolates differ from laboratory strains in their interaction with two cell surface receptors. J Infect Dis 175: 697-700.
31. Coyne CB, Bergelson JM, (2005) CAR: a virus receptor within the tight junction. Adv Drug Deliv Rev 57: 869-882.
32. Cherubini G, Petouchoff T, Grossi M, Piersanti S, Cundari E, et al. (2006) E1B55K-deleted adenovirus (ONYX-015) overrides G1/S and G2/M checkpoints and causes mitotic catastrophe and endoreduplication in p53-proficient normal cells. Cell Cycle 5: 2244-2252.
33. Hu F, Hu XH, Yu P, Zhang JX, Lou GG, et al. (2006) [Abscopal effect on metastatic tumor induced by oncolytic virus of H101 combining with local heating]. Ai Zheng 25: 919-924.
34. Qian CF, Yan W, Zhang JX, Shi L, Qian J, et al. (2009) Notch1 induces enhanced expression of Delta-like-1 in the U251MG glioma cell line. Int J Mol Med 24: 445-451.
35. Moriyama M, Osawa M, Mak SS, Ohtsuka T, Yamamoto N, et al. (2006) Notch signaling via Hes1 transcription factor maintains survival of melanoblasts and melanocyte stem cells. J Cell Biol 173: 333-339.
36. Suzuki T, Aoki D, Susumu N, Udagawa Y, Nozawa S, (2000) Imbalanced expression of TAN-1 and human Notch4 in endometrial cancers. Int J Oncol 17: 1131-1139.
37. Zagouras P, Stifani S, Blaumueller CM, Carcangiu ML, Artavanis-Tsakonas S, (1995) Alterations in Notch signaling in neoplastic lesions of the human cervix. Proc Natl Acad Sci U S A 92: 6414-6418.
38. Leethanakul C, Patel V, Gillespie J, Pallente M, Ensley JF, et al. (2000) Distinct pattern of expression of differentiation and growth-related genes in squamous cell carcinomas of the head and neck revealed by the use of laser capture microdissection and cDNA arrays. Oncogene 19: 3220-3224.
39. Rae FK, Stephenson SA, Nicol DL, Clements JA, (2000) Novel association of a diverse range of genes with renal cell carcinoma as identified by differential display. Int J Cancer 88: 726-732.
40. Brennan K, Brown AM, (2003) Is there a role for Notch signalling in human breast cancer? Breast Cancer Res 5: 69-75.
41. Kirschmann DA, Seftor EA, Fong SF, Nieva DR, Sullivan CM, et al. (2002) A molecular role for lysyl oxidase in breast cancer invasion. Cancer Res 62: 4478-4483.
42. Aster JC, Pear WS, (2001) Notch signaling in leukemia. Curr Opin Hematol 8: 237-244.
43. Weijzen S, Rizzo P, Braid M, Vaishnav R, Jonkheer SM, et al. (2002) Activation of Notch-1 signaling maintains the neoplastic phenotype in human Ras-transformed cells. Nat Med 8: 979-986.
44. Cun B, Song X, Jia R, Zhao X, Wang H, et al. (2012) Combination of oncolytic adenovirus and dacarbazine attenuates antitumor ability against uveal melanoma cells via cell cycle block. Cancer Biol Ther 13: 77-84.
45. Jia R, Jiao Z, Xu X, Wang J, Zhou Y, et al. (2011) Functional significance of B7-H1 expressed by human uveal melanoma cells. Mol Med Report 4: 163-167.
46. Kan-Mitchell J, Mitchell MS, Rao N, Liggett PE, (1989) Characterization of uveal melanoma cell Lines that grow as xenografts in rabbit eyes. Invest Ophthalmol Vis Sci 30: 829-834.
47. Albert DM, Ruzzo MA, McLaughlin MA, Robinson NL, et al. (1984) Establishment of cell lines of uveal melanoma. Methodology and characteristics. Invest Ophthalmol Vis Sci 25: 1284-1299.